logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Serotonin-1b and Serotonin-1d Receptor Agonist class drugs

    FiltersReset Filters
    10 results

    • almotriptan

      (almotriptan)
      Ajanta Pharma USA Inc.
      Usage: Almotriptan tablets are indicated for the acute treatment of migraine attacks in adults and adolescents (ages 12 to 17) with a history of migraines, with or without aura. They are not intended for the prophylaxis of migraine or the treatment of hemiplegic or basilar migraine.

    • frovatriptan

      (frovatriptan succinate)
      Ingenus Pharmaceuticals, LLC
      Usage: Frovatriptan succinate tablets are indicated for the acute treatment of migraines with or without aura in adults. They should only be used after a clear migraine diagnosis and are not for migraine prevention or cluster headache treatment.

    • imitrex

      (sumatriptan)
      GlaxoSmithKline LLC
      Usage: IMITREX injection is indicated for the acute treatment of migraine and cluster headache in adults. It should only be used with a confirmed diagnosis, and is not intended for the prevention of these headaches. If there is no response to initial treatment, the diagnosis should be re-evaluated.

    • imitrex

      (sumatriptan)
      GlaxoSmithKline LLC
      Usage: IMITREX tablets are indicated for the acute treatment of migraine with or without aura in adults. It is not for migraine prevention or for treating cluster headaches, and should only be used if a clear migraine diagnosis is established.

    • onzetra xsail

      (sumatriptan succinate)
      Currax Pharmaceuticals LLC
      Usage: ONZETRA® Xsail® is indicated for the acute treatment of migraine with or without aura in adults. It is not intended for migraine prevention or the treatment of cluster headaches. A clear migraine diagnosis must be established prior to use.

    • relpax

      (eletriptan hydrobromide)
      ROERIG
      Usage: RELPAX is indicated for the acute treatment of migraine in adults, with or without aura. It should only be used after a clear migraine diagnosis is established and is not intended for migraine prevention or for treating cluster headaches.

    • sumatriptan and naproxen sodium

      (Sumatriptan and Naproxen Sodium)
      NorthStar RxLLC
      Usage: Sumatriptan and naproxen sodium tablets are indicated for the acute treatment of migraine with or without aura in adults and pediatric patients aged 12 and older. They are not for migraine prevention or cluster headache treatment, and a confirmed migraine diagnosis is necessary before use.

    • tosymra

      (sumatriptan)
      Upsher-Smith Laboratories, LLC
      Usage: TOSYMRA is indicated for the acute treatment of migraine with or without aura in adults. It should only be used with a confirmed migraine diagnosis and is not intended for migraine prevention or the treatment of cluster headaches.

    • treximet

      (Sumatriptan Succinate and Naproxen Sodium)
      Currax Pharmaceuticals LLC
      Usage: TREXIMET is indicated for the acute treatment of migraine with or without aura in adults and pediatric patients aged 12 years and older. It is not intended for migraine prevention or cluster headaches and requires a confirmed diagnosis of migraine before use.

    • zembrace symtouch

      (Sumatriptan Succinate)
      Upsher-Smith laboratories, LLC
      Usage: ZEMBRACE SymTouch is indicated for the acute treatment of migraine in adults, with or without aura. It should only be used with a confirmed migraine diagnosis and is not meant for preventing migraines. If no response occurs after the first use, re-evaluation of the diagnosis is necessary.